BAIT
TIPARP
ARTD14, PARP7, pART14
TCDD-inducible poly(ADP-ribose) polymerase
GO Process (3)
GO Function (2)
GO Component (1)
Gene Ontology Biological Process
Gene Ontology Molecular Function
Homo sapiens
PREY
ABL2
ABLL, ARG, RP11-177A2.3
ABL proto-oncogene 2, non-receptor tyrosine kinase
GO Process (21)
GO Function (9)
GO Component (3)
Gene Ontology Biological Process
- axon guidance [TAS]
- cell migration [IBA]
- cellular protein modification process [TAS]
- cellular response to retinoic acid [IMP]
- epidermal growth factor receptor signaling pathway [IBA]
- innate immune response [IBA]
- peptidyl-tyrosine autophosphorylation [IBA]
- peptidyl-tyrosine phosphorylation [IDA]
- platelet-derived growth factor receptor signaling pathway [IBA]
- positive regulation of cytosolic calcium ion concentration [IMP]
- positive regulation of neuron projection development [IMP]
- positive regulation of oxidoreductase activity [IDA]
- positive regulation of phospholipase C activity [IMP]
- regulation of actin cytoskeleton reorganization [TAS]
- regulation of apoptotic process [IBA]
- regulation of autophagy [TAS]
- regulation of cell adhesion [TAS]
- regulation of cell motility [TAS]
- regulation of cell proliferation [IBA]
- regulation of endocytosis [TAS]
- signal transduction [TAS]
Gene Ontology Molecular Function
Gene Ontology Cellular Component
Homo sapiens
Affinity Capture-MS
An interaction is inferred when a bait protein is affinity captured from cell extracts by either polyclonal antibody or epitope tag and the associated interaction partner is identified by mass spectrometric methods.
Publication
A Whole-Genome CRISPR Screen Identifies AHR Loss as a Mechanism of Resistance to a PARP7 Inhibitor.
Inhibitors directed toward PARP1 and PARP2 are approved agents for the treatment of BRCA1 and BRCA2-related cancers. Other members of the PARP family have also been implicated in cancer and are being assessed as therapeutic targets in cancer and other diseases. Recently, an inhibitor of PARP7 (RBN-2397) has reached early-stage human clinical trials. Here, we performed a genome-wide CRISPR screen ... [more]
Mol Cancer Ther Jul. 05, 2022; 21(7);1076-1089 [Pubmed: 35439318]
Throughput
- High Throughput
Curated By
- BioGRID